{
  "abstract": "This case series examines viral suppression outcomes among patients with HIV with prior adherence challenges, treatment experience, and resistance initiating lenacapavir and cabotegravir.",
  "abstract_shown": true,
  "affiliations": [
    "Division of HIV, ID, and Global Medicine, University of California, San Francisco"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 11,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Nathanael L. Gistand"
    },
    {
      "affs": [
        0
      ],
      "name": "Ishaan C. Mishra"
    },
    {
      "affs": [
        0
      ],
      "name": "Kyle Hunter"
    },
    {
      "affs": [
        0
      ],
      "name": "Megan J. Heise"
    },
    {
      "affs": [
        0
      ],
      "name": "Chesa Cox"
    },
    {
      "affs": [
        0
      ],
      "name": "Janet Grochowski"
    },
    {
      "affs": [
        0
      ],
      "name": "Francis Mayorga-Munoz"
    },
    {
      "affs": [
        0
      ],
      "name": "Jon Oskarsson"
    },
    {
      "affs": [
        0
      ],
      "name": "Mary Shiels"
    },
    {
      "affs": [
        0
      ],
      "name": "Matthew A. Spinelli"
    },
    {
      "affs": [
        0
      ],
      "name": "Monica Gandhi"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/eg2vxyw2syny1.bib",
  "cited_by": 0,
  "doi": "10.1001/jamanetworkopen.2026.38182",
  "fulltext_url": null,
  "id": "eg2vxyw2syny1",
  "issns": [
    "2574-3805"
  ],
  "landing_url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854975",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2725|HIV/AIDS drug development and treatment"
    ]
  ],
  "openalex": "W7221055256",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-08",
  "publisher": "American Medical Association (AMA)",
  "ris": "https://research.draconitic.com/paper/eg2vxyw2syny1.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:19:46Z",
      "native_id": "10.1001/jamanetworkopen.2026.38182",
      "source": "crossref",
      "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854975"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2725|HIV/AIDS drug development and treatment",
      "subfield": "infectious-disease"
    }
  ],
  "title": "Long-Acting Lenacapavir and Cabotegravir and Viral Suppression Among People With HIV",
  "title_text": "Long-Acting Lenacapavir and Cabotegravir and Viral Suppression Among People With HIV",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:19:46Z",
  "url": "https://research.draconitic.com/paper/eg2vxyw2syny1",
  "venue": "JAMA Network Open",
  "versions": []
}